Selecting the right therapeutic target for kidney disease.
Buvall L, Menzies RI, Williams J, Woollard KJ, Kumar C, Granqvist AB, Fritsch M, Feliers D, Reznichenko A, Gianni D, Petrovski S, Bendtsen C, Bohlooly-Y M, Haefliger C, Danielson RF, Hansen PBL.
Front Pharmacol. 2022 Nov 2;13:971065. doi: 10.3389/fphar.2022.971065. eCollection 2022.
PMID:36408217
The case for not masking away repetitive DNA.
Slotkin RK.
Mob DNA. 2018 May 1;9:15. doi: 10.1186/s13100-018-0120-9. eCollection 2018.
PMID:29743957
Stop the Divide: Facilitators and Barriers to Uptake of Digital Health Interventions Among Socially Disadvantaged Populations.
Price-Haywood EG, Arnold C, Harden-Barrios J, Davis T.
Ochsner J. 2023 Spring;23(1):34-42. doi: 10.31486/toj.22.0101.
PMID:36936477
A patient-centric pathway for testicular cancer - A multicentre study investigating the uptake of semen cryopreservation and impact on treatment.
Scott C, Omar K, Alnajjar HM, Alifrangis C, Ahmed K, Muneer A.
Andrology. 2021 May;9(3):823-828. doi: 10.1111/andr.12984. Epub 2021 Feb 28.
PMID:33527714
Azathioprine monotherapy withdrawal in inflammatory bowel diseases: A retrospective mono-centric study.
Crepaldi M, Maniero D, Massano A, Pavanato M, Barberio B, Savarino EV, Zingone F.
World J Gastroenterol. 2023 Jul 21;29(27):4334-4343. doi: 10.3748/wjg.v29.i27.4334.
PMID:37545640
Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases.
Dhaenens BAE, Heimann G, Bakker A, Nievo M, Ferner RE, Evans DG, Wolkenstein P, Leubner J, Potratz C, Carton C, Iloeje U, Kirk G, Blakeley JO, Plotkin S, Fisher MJ, Kim A, Driever PH, Azizi AA, Widemann BC, Gross A, Parke T, Legius E, Oostenbrink R.
Neurooncol Pract. 2024 Jan 4;11(4):395-403. doi: 10.1093/nop/npae001. eCollection 2024 Aug.